Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 15.420\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: CSCCC(C(=O)O)N1C(=O)/C(=C/c2cccn2C)SC1=S
b: CCc1ccccc1N(CC(=O)NC(C)c1ccccc1)S(C)(=O)=O
c: Cc1cc(NC(=O)c2ccc3c(c2)C(=O)N(Cc2cccnc2)C3=O)no1
d: Cc1c(NC(=O)CS(=O)(=O)c2ccccc2)c(=O)n(-c2ccccc2)n1C
e: Nc1nc(Cl)cc(Oc2ccc([N+](=O)[O-])cc2)n1
Answer: a. CSCCC(C(=O)O)N1C(=O)/C(=C/c2cccn2C)SC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(C(=O)O)N1C(=O)/C(=C/c2cccn2C)SC1=S
CSCCC(C(=O)O)N1C(=O)/C(=C/c2cccn2C)SC1=S
2-[(5Z)-5-[(1-methylpyrrol-2-yl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-4-methylsulfanylbutanoic acid